Patents by Inventor Paul M. Bowen

Paul M. Bowen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220362233
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Application
    Filed: July 25, 2022
    Publication date: November 17, 2022
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • Patent number: 11426398
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: August 30, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen